Michigan EMS. Medication In-Service: Ondansetron (Zofran) ODT
|
|
- Mercy Gray
- 5 years ago
- Views:
Transcription
1 Michigan EMS Medication In-Service: Ondansetron (Zofran) ODT
2 Course Objectives Identify the location of ondansetron (Zofran) ODT in the SEM Drug Box, as well as how it may be packaged. Describe the pharmacokinetics and pharmacodynamics of ondansetron (Zofran) ODT. List the indications and contraindications of ondansetron (Zofran) ODT. Describe how to administer ondansetron (Zofran) ODT, as well as list the applicable medication concentration, route and dose per the applicable protocols.
3 Introduction Purpose As of June 1, 2018, the following medications were added to the Southeast Michigan Regional Medication Boxes (SEM Drug Box): Ketamine Ketorolac (Toradol) Push Dose Epinephrine Ondansetron (Zofran) ODT
4 Introduction Purpose This CE will focus on: Ondansetron (Zofran) ODT Orally Disintegrating Tablet (ODT)
5 Location in the SEM Drug Box Two 4mg tablets will be stocked in the drug box
6 Location in the SEM Drug Box Ondansetron ODT will NOT be found in the A-Packs
7 Location in the SEM Drug Box Freeze dried formulation of ondansetron Disintegrates rapidly on the tongue Water is not utilized or necessary to administer
8 Location in the SEM Drug Box Shape: plano-convex One side is flat and the other is convex
9 Location in the SEM Drug Box Imprint: The tablets will have a Z4 imprint Stands for Zofran 4mg
10 Pharmacokinetics and Pharmacodynamics Class of medication Antiemetic (prevents vomiting) Serotonin receptor antagonist Blocks serotonin from binding with serotonin receptor sites Prevents vomiting impulses from being sent to the brain and suppresses nausea and vomiting
11 Pharmacokinetics and Pharmacodynamics Mechanism of action Ondansetron (Zofran) ODT is used to prevent and/or alleviate nausea and vomiting that results from a serotonin release
12 Pharmacokinetics and Pharmacodynamics Route of administration Ondansetron (Zofran) ODT is administered orally, but is not swallowed whole: The tablet is placed on the patient s tongue The patient is instructed to swallow several times as the tablet rapidly dissolves The saliva transports the dissolved medication to the patient s GI tract
13 Pharmacokinetics and Pharmacodynamics Onset and duration of action Ondansetron (Zofran) ODT has a rapid onset. In addition: Peak antiemetic effect is observed between 15 to 30 minutes after onset Duration of action for ondansetron (Zofran) ODT is 4 to 8 hours Effects will remain the entire time the patient is being treated by EMS
14 Pharmacokinetics and Pharmacodynamics Half-life Approximately 4 hours in the adult patient The body is able to effectively metabolize ondansetron
15 Pharmacokinetics and Pharmacodynamics Side effects Drowsiness Headache Weakness Dry mouth A rash may occur in 1% of patients Patients receiving ondansetron (Zofran) ODT on a continued basis may report constipation
16 Pharmacokinetics and Pharmacodynamics Side effects May cause the QT interval to lengthen slightly In rare cases, this can cause cardiac arrhythmias including torsades de pointes
17 Pharmacokinetics and Pharmacodynamics Side effects Other cardiac side effects (rare): Hypotension Tachycardia Strong consideration should be given to monitor the patient s heart rhythm before, during and after administration
18 Indications Ondansetron (Zofran) ODT SHOULD be administered in the following situations: Patients 40kg (88lbs) complaining of nausea and/or vomiting Patients experiencing nausea after receiving opioid medications for pain management
19 Indications Ondansetron (Zofran) ODT: It will reduce nausea, prevent future vomiting and enhance patient comfort Do not administer while the patient is actively vomiting
20 Indications Ondansetron (Zofran) ODT: Keep in mind: Vomiting can lead to serious illness Severe vomiting can lead to dehydration and electrolyte imbalances, if untreated Uncontrolled vomiting can lead to airway compromise Effective management of nausea and vomiting is safe practice for EMS Contaminated vomit increases the risk of exposure
21 Contraindications Ondansetron (Zofran) ODT should NOT be administered in the following situations: Patients that are <40kg Patients actively vomiting in the presence of EMS should receive IV/IM ondansetron (Zofran), instead
22 Contraindications Ondansetron (Zofran) ODT should NOT be administered in the following situations: Patients allergic to ondansetron or other serotonin receptor antagonists Examples: Tropisetron Palonsetron Ramosetron These types of meds typically end in tron
23 Contraindications Ondansetron (Zofran) ODT should NOT be administered in the following situations: Patients with phenylketonuria (PKU): Inability to metabolize phenylalanine Ondansetron ODT contains phenylalanine Administer IV/IM ondansetron instead
24 Additional information to consider The following circumstances represent situations that require special attention: Patients with long QT syndrome May be congenital or acquired Ondansetron ODT can increase the risk of arrhythmia and sudden cardiac death Normal QT Interval Long QT Interval
25 Additional information to consider The following circumstances represent situations that require special attention: If ondansetron (Zofran) ODT is administered put the patient on the EKG monitor if they re experiencing: Electrolyte imbalances Bradycardia Congestive heart failure Hypomagnesemia Hypokalemia
26 Additional information to consider The following circumstances represent situations that require special attention: Pregnant patients should avoid the use of ondansetron (Zofran) ODT unless it is clearly needed to safely manage patient care Especially in the first trimester
27 Additional information to consider The following circumstances represent situations that require special attention: Patients taking apomorphine should avoid the use of ondansetron (Zofran) ODT Medication prescribed to treat Parkinson s It may cause hypotension and unconsciousness
28 Applicable protocols Nausea & Vomiting (general treatment section)
29 Applicable protocols Nausea & Vomiting (general treatment section)
30 Applicable protocols Nausea & Vomiting (general treatment section)
31 Applicable protocols Nausea & Vomiting (general treatment section) Patient must be >40kg Administer IM/IV for patient s <40kg Do not administer ondansetron ODT if the patient is actively vomiting Administer IM/IV instead Repeat doses require online Medical Control approval
32 Applicable protocols Pain Management (procedure section)
33 Applicable protocols Pain Management (procedure section) Patient must be >40kg Administer IM/IV for patient s <40kg Do not administer ondansetron ODT if the patient is actively vomiting Administer IM/IV instead A single repeat dose DOES NOT require online medical control approval for this protocol
34 How to administer ondansetron ODT 1. Remove ondansetron (Zofran) ODT from the SEM Drug Box
35 How to administer ondansetron ODT 2. Verify the correct medication and dosage Ondansetron ODT Dose: 4mg Imprint: A Z4 will be imprinted on the tablet
36 How to administer ondansetron ODT 3. Remove ondansetron (Zofran) ODT from the foil blister pack PEEL THE TAB! DON T push out the tablet! Assure your gloved hands are dry Moisture will damage the tablet
37 How to administer ondansetron ODT 4. Place ondansetron (Zofran) ODT on top of the patient s tongue Explain to the patient that the medication will dissolve within seconds Instruct the patient not to chew or swallow the medication whole while it is dissolving
38 How to administer ondansetron ODT 5. Instruct the patient to swallow their saliva Instruct the patient to swallow their saliva several times This will ensure the medication enters the GI tract, as intended
39 How to administer ondansetron ODT 6. Monitor the patient Monitor the patient for the desired effect The medication will have peak effect within minutes
40 How to administer ondansetron ODT 6. Monitor the patient If the patient is still experiencing nausea and/or vomiting after minutes: Nausea/Vomiting Protocol administer a second dose after obtaining approval from online Medical Control Pain Management Procedure Administer a second dose without online Medical Control
41 Medication Section 9 Every medication available in the SEM Drug Box and A-Pack is now detailed in Section 9 Medications of the State of Michigan EMS Protocols Click here to access the digital version of Section 9
42 Medication Section 9 Ondansetron 9-29 Applicable Protocols Indications Contraindications Dosing: Adult Pediatrics Expected Effects Side Effects
43 Michigan EMS Medication In-Service: Ondansetron (Zofran) ODT Questions???
Michigan EMS. Medication In-Service: Ondansetron (Zofran) ODT. Instructor Resource Guide. Format: Lecture
Instructor Resource Guide Format: Lecture Purpose: This EMS continuing education (CE) is designed to familiarize Michigan s Southeast Region paramedics with the administration of ondansetron (Zofran) ODT
More informationOndansetron blocks the actions of chemicals in the body that can trigger nausea and vomiting.
1 of 6 6/10/2016 4:54 PM Generic Name: ondansetron (oral) (on DAN se tron) Brand Names: Zofran, Zofran ODT, Zuplenz What is ondansetron? Ondansetron blocks the actions of chemicals in the body that can
More informationMichigan EMS. Medication In-Service: Ketorolac (Toradol) Instructor Resource Guide. Format: Lecture
Instructor Resource Guide Format: Lecture Purpose: This EMS continuing education (CE) is designed to familiarize Michigan s Southeast Region paramedics with the administration of ketorolac (Toradol) when
More informationIt is used to treat or prevent upset stomach and throwing up. What do I need to tell my doctor BEFORE I take this drug?
PATIENT & CAREGIVER EDUCATION Ondansetron Brand Names: US Zofran; Zofran ODT [DSC]; Zuplenz Brand Names: Canada Ondissolve ODF; Zofran ODT What is this drug used for? It is used to treat or prevent upset
More informationMichigan EMS. Medication In-Service: Push Dose Epinephrine. Instructor Resource Guide. Format: Lecture
Instructor Resource Guide Format: Lecture Purpose: This EMS continuing education (CE) is designed to familiarize Michigan s Southeast Region paramedics with the administration of push dose epinephrine
More informationWhat Ondansetron ODT GH orally disintegrating tablets are used for. belong to a group of medicines called antiemetics.
CONSUMER MEDICINE INFORMATION Orally disintegrating Ondansetron What is in this leaflet? Please read this leaflet carefully before you start GH. This leaflet answers some common questions about disintegrating.
More informationONCE-DAILY DOSING WITH NUPLAZID
YOUR GUIDE TO ONCE-DAILY DOSING WITH NUPLAZID NUPLAZID (pimavanserin) is the first and only FDAapproved treatment for hallucinations and delusions associated with Parkinson s disease psychosis 1 Indication
More information1 What Zofran Zydis is and what it is used for
GlaxoSmithKline (logo) Package Leaflet: Information for the User Zofran Zydis 4 mg and 8 mg Oral Lyophilisate ondansetron Read all of this leaflet carefully before you start taking this medicine because
More informationMICHIGAN. Table of Contents. State Protocols. General Treatment Protocols
MICHIGAN State Protocols General Treatment Protocols Table of Contents Protocol Number Protocol Name 1.1 General Pre-hospital Care: Regional Protocol 1.2 Abdominal Pain 1.3 Nausea and Vomiting: Regional
More informationOndansetron apollo Ondansetron apollo Ondansetron
Ondansetron apollo +9191 46 950 950 Ondansetron apollo +9191 46 950 950 Ondansetron CAS Number : 99614-02-5 Molecular Formula : C18H19N3O Molecular Weight : 293.36 g/mol Systematic (IUPAC) : 9-methyl-3-[(2-methyl-1H-
More informationSAEMS. Ondansetron HCL Self-Learning Module
SAEMS Ondansetron HCL Self-Learning Module Dawn Daniels Tucson Medical Center November, 2008 1 DATE: November 2008 PURPOSE TRAINING MODULE FOR ONDANSETRON This Training Module has been developed to serve
More information2 What you need to know before you use Zofran Suppositories
Package Leaflet: Information for the User Zofran 16 mg Suppositories ondansetron Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
More information1 What Zofran Suppositories are and what they are used for
GlaxoSmithKline (logo) Package Leaflet: Information for the User Zofran 16 mg Suppositories ondansetron Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPackage leaflet: Information for the user. Nocdurna 25 microgram oral lyophilisate Nocdurna 50 microgram oral lyophilisate.
Package leaflet: Information for the user Nocdurna 25 microgram oral lyophilisate Nocdurna 50 microgram oral lyophilisate desmopressin Read all of this leaflet carefully before you start taking this medicine
More informationMICHIGAN. State Protocols. General Treatment Protocols Table of Contents
MICHIGAN State Protocols Protocol Number 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 General Treatment Protocols Table of Contents Protocol Name General Pre-hospital Care Abdominal Pain Nausea
More informationPRODUCT MONOGRAPH. Pr KYTRIL. granisetron hydrochloride tablets. 1 mg granisetron as hydrochloride. Manufacture Standard
PRODUCT MONOGRAPH Pr KYTRIL granisetron hydrochloride tablets 1 mg granisetron as hydrochloride Manufacture Standard Antiemetic (5-HT 3 receptor antagonist) Hoffmann-La Roche Limited Date of Revision:
More informationZofran dosage by weight
Zofran dosage by weight Search Now enrolling students for the VPK 2018-2019 school year!. Zofran official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions,
More informationAPO-Ondansetron Contains the active ingredient, ondansetron (as hydrochloride dihydrate)
APO-Ondansetron Contains the active ingredient, ondansetron (as hydrochloride dihydrate) Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read
More informationZofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.
Package Leaflet: Information for the User Zofran 4 mg/5 ml Syrup Ondansetron Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPackage Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate)
Novartis (logo) Package Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate) Read all of this leaflet carefully before you start taking this medicine
More informationZofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.
Package Leaflet: Information for the User Zofran 4 mg or 8 mg Film coated Tablets Ondansetron Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPackage leaflet: Information for users. Imodium 2 mg orodispersible tablets Loperamide hydrochloride
MARKETING AUTHORISATION NO. 7810/2015/01-02-03-04 Annex 1 Package leaflet Package leaflet: Information for users Imodium 2 mg orodispersible tablets Loperamide hydrochloride Read all of this leaflet carefully
More informationEMESET Tablets (Ondansetron hydrochloride)
Published on: 10 Jul 2014 EMESET Tablets (Ondansetron hydrochloride) Composition EMESET 4 Tablets Each film coated tablet contains Ondansetron hydrochloride Equivalent to Ondansetron...4 mg EMESET 8 Tablets
More informationNuplazid. (pimavanserin) New Product Slideshow
Nuplazid (pimavanserin) New Product Slideshow Introduction Brand name: Nuplazid Generic name: Pimavanserin Pharmacological class: Atypical antipsychotic Strength and Formulation: 17mg; tablets Manufacturer:
More informationPackage leaflet: Information for the patient. Sycrest 5 mg sublingual tablets Sycrest 10 mg sublingual tablets asenapine
Package leaflet: Information for the patient Sycrest 5 mg sublingual tablets Sycrest 10 mg sublingual tablets asenapine Read all of this leaflet carefully before you start taking this medicine because
More informationPackage Leaflet: Information for the User. Zomig Rapimelt 2.5 mg and 5 mg orodispersible tablets zolmitriptan
Package Leaflet: Information for the User Zomig Rapimelt 2.5 mg and 5 mg orodispersible tablets zolmitriptan Read all of this leaflet carefully before you start taking this medicine because it contains
More informationAustedo. (deutetrabenazine) New Product Slideshow
Austedo (deutetrabenazine) New Product Slideshow Introduction Brand name: Austedo Generic name: Deutetrabenazine Pharmacological class: Vesicular monoamine transporter 2 (VMAT2) inhibitor Strength and
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. MEPHENON 10mg/1ml, solution for injection MEPHENON 5mg, tablets. Methadone hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER MEPHENON 10mg/1ml, solution for injection MEPHENON 5mg, tablets Methadone hydrochloride Read all of this leaflet carefully before you start using this medicine
More informationACADIA Pharmaceuticals Issues Statement Reaffirming Benefit/Risk Profile of NUPLAZID
ACADIA Pharmaceuticals Issues Statement Reaffirming Benefit/Risk Profile of NUPLAZID Concurrently, the Company Has Issued a Press Release Announcing the Presentation of Clinical Experience Data for NUPLAZID
More informationMedication Guide BELBUCATM (bel-bue-kuh) (buprenorphine) buccal film, CIII BELBUCA is:
Medication Guide BELBUCA TM (bel-bue-kuh) (buprenorphine) buccal film, CIII BELBUCA is: A strong prescription pain medicine that contains an opioid (narcotic) that is used to manage pain severe enough
More informationDoctor Discussion Guide
Doctor Discussion Guide Getting the pain relief you need to stay active is important. Keeping track of your symptoms can help you and your healthcare provider determine if there is a need to adjust your
More informationPRODUCT CIRCULAR. Tablets COZAAR (losartan potassium) I. THERAPEUTIC CLASS II. INDICATIONS III. DOSAGE AND ADMINISTRATION PAK-CZR-T
PRODUCT CIRCULAR Tablets I. THERAPEUTIC CLASS, the first of a new class of agents for the treatment of hypertension, is an angiotensin II receptor (type AT 1 ) antagonist. also provides a reduction in
More informationChange in Practice PCP Autonomous IV OBHG Education Subcommittee
Change in Practice PCP Autonomous IV Intravenous and Fluid Therapy Medical Directive Auxiliary Ability to initiate IV access and Ability to administer fluid and fluid boluses in general IV Therapy Actual
More informationZofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.
GlaxoSmithKline (logo) Package Leaflet: Information for the User Zofran 4 mg/5 ml Syrup Ondansetron Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationActive Ondansetron. Virtual SPC for PSUR Synchronisation Scheme
Active Ondansetron Virtual SPC for PSUR Synchronisation Scheme This Virtual SPC is based on GlaxoSmithKline s Company Core Data Sheet (CCDS) for ondansetron. GSK does not believe that there are deficiencies
More informationIrbenida H 150mg/12,5mg film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Irbenida H 150mg/12,5mg film-coated tablets IRBESARTAN/HYDROCHLOROTHIAZIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information
More informationGuide for Patients and Caregivers
N FENTORA Fentanyl Buccal/Sublingual Effervescent Tablets 100 mcg, 200 mcg, 400 mcg, 600 mcg, and 800 mcg fentanyl as fentanyl citrate Opioid Analgesic Guide for Patients and Caregivers Manufactured for:
More informationSee 17 for PATIENT COUNSELING INFORMATION. Revised: 10/2017
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZOFRAN TABLETS, ZOFRAN ODT, and ZOFRAN ORAL SOLUTION safely and effectively. See full prescribing
More informationSTART THE CONVERSATION
START THE CONVERSATION ABOUT PARKINSON S DISEASE PSYCHOSIS Your patients with Parkinson s disease (PD) psychosis may be hesitant to report their symptoms LEARN MORE about how to identify the symptoms of
More informationA Helpful Guide When Starting
A Helpful Guide When Starting Approved Uses AUSTEDO is a prescription medicine that is used to treat: the involuntary movements (chorea) of Huntington s disease. AUSTEDO does not cure the cause of the
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Ondansetron BMM Pharma 8 mg film-coated tablets. Ondansetron
PACKAGE LEAFLET: INFORMATION FOR THE USER Ondansetron BMM Pharma 4 mg film-coated tablets Ondansetron BMM Pharma 8 mg film-coated tablets Ondansetron Read all of this leaflet carefully before you start
More informationUnderstanding your take home medications from the surgical ward. Information for Patients
Understanding your take home medications from the surgical ward Information for Patients i Information for Patients Please read this leaflet before taking the medications that have been prescribed for
More informationPackage leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine
Package leaflet: Information for the user Ebateva 10 mg Orodispersible Tablets Ebateva 20 mg Orodispersible Tablets Ebastine Read all of this leaflet carefully before you start taking this medicine because
More informationLACIPIL QUALITATIVE AND QUANTITATIVE COMPOSITION
LACIPIL lacidipine QUALITATIVE AND QUANTITATIVE COMPOSITION Lacidipine, 2 mg - round shaped white engraved on one face. Lacidipine, 4 mg - oval white with break line on both faces. Lacidipine, 6 mg - oval
More informationPackage Leaflet: Information for the User Zotron 4mg/2ml (ή 8mg/4ml) Solution for Injection or Infusion ondansetron
Package Leaflet: Information for the User Zotron 4mg/2ml (ή 8mg/4ml) Solution for Injection or Infusion ondansetron Read all of this leaflet carefully before you start taking this medicine because it contains
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Page 1 of 7
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS Page 1 of 7 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Prilocard 5mg tablets for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active
More informationFacts About BELBUCA (buprenorphine) Buccal Film
Facts About BELBUCA (buprenorphine) Buccal Film Indication BELBUCA is a recent FDA-approved medication for the treatment of chronic pain severe enough to require daily, around-the-clock, long-term opioid
More informationOdactra (house dust mite allergen extract) NEW PRODUCT SLIDESHOW
Odactra (house dust mite allergen extract) NEW PRODUCT SLIDESHOW Introduction Brand name: Odactra Generic name: House dust mite allergen extract (Dermatophagoides farinae, Dermatophagoides pteronyssinus)
More informationAdenosine. poison/drug induced. flushing, chest pain, transient asystole. Precautions: tachycardia. fibrillation, atrial flutter. Indications: or VT
Adenosine Indications: 1. Narrow complex PSVT 2. Does not convert atrial fibrillation, atrial flutter or VT 1. Side effects include flushing, chest pain, transient asystole 2. May deteriorate widecomplex
More informationDYSRHYTHMIAS. D. Assess whether or not it is the arrhythmia that is making the patient unstable or symptomatic
DYSRHYTHMIAS GENERAL CONSIDERATIONS A. The 2015 American Heart Association Guidelines were referred to for this protocol development. Evidence-based science was implemented in those areas where the AHA
More information2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Summary of Product Characteristics 1. NAME OF THE MEDICINAL PRODUCT {To be completed nationally} 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 mg tablets: each tablet contains 1 mg granisetron (as hydrochloride).
More informationAdult Drug Reference. Dopamine Drip Chart. Pediatric Drug Reference. Pediatric Drug Dosage Charts DRUG REFERENCES
Adult Drug Reference Dopamine Drip Chart Pediatric Drug Reference Pediatric Drug Dosage Charts DRUG REFERENCES ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments ADENOSINE Paroxysmal
More informationPOSTOP CARE FOR WISDOM TEETH
POSTOP CARE FOR WISDOM TEETH Bleeding Bleeding after surgery may continue for several hours. The best way to stop bleeding is to place a piece of folded, damp gauze over the extraction site and gently
More informationDocument 3 Summary of Data and Guidance for Medical Professionals
Document 3 Summary of Data and Guidance for Medical Professionals Anvirzel Anvirzel is a novel antitumor compound extracted from the plant Nerium oleander, which belongs to the family Apocynaceae. Anvirzel
More informationPART III: CONSUMER INFORMATION SAPHRIS (asenapine sublingual tablets)
PART III: CONSUMER INFORMATION SAPHRIS (asenapine sublingual tablets) This leaflet is part III of a three-part "Product Monograph" published when SAPHRIS was approved for sale in Canada and is designed
More informationComposition: Each tablet contain. Levocetirizine. Each 5ml contains. Montelukast. Pharmacokinetic properties:
Composition: Each tablet contain Montelukast Levocetirizine 10mg 5mg Each 5ml contains Montelukast Levocetirizine 4mg 2.5mg Pharmacokinetic properties: Peak plasma concentrations of montelukast are achieved
More informationPOSTOP CARE FOR TOOTH EXTRACTION
POSTOP CARE FOR TOOTH Bleeding EXTRACTION Bleeding after surgery may continue for several hours. The best way to stop bleeding is to place a piece of folded, damp gauze over the extraction site and gently
More informationPackage leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides
Package leaflet: Information for the user SenEase 7.5 mg tablets Sennosides Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep
More informationNURSING PROCESS FOCUS: Patients Receiving Amphotericin B (Fungizone, Abelcet)
NURSING PROCESS FOCUS: Patients Receiving Amphotericin B (Fungizone, Abelcet) ASSESSMENT Prior to administration: Obtain complete health history including allergies, drug history, and possible drug interactions.
More informationPATIENT INFORMATION LEAFLET BILOCOR RANGE
SCHEDULING STATUS: S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM BILOCOR 5 tablets BILOCOR 10 tablets Please read this leaflet carefully before using BILOCOR 5 / 10 mg tablets Keep this leaflet.
More informationPackage leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)
Package leaflet: Information for the patient Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride) Read all of this leaflet carefully before you start taking this medicine because
More informationCare for patients with Neurological disorders
King Saud University College of Nursing Medical Surgical Department Application of Adult Health Nursing Skills ( NUR 317 ) Care for patients with Neurological disorders Outline; EEG Overview. Nursing Interventions;
More informationEuropean Medicines Agency recommends changes to the use of metoclopramide
20 December 2013 EMA/13239/2014 Corr. 1 European Medicines Agency recommends changes to the use of metoclopramide Changes aim mainly to reduce the risk of neurological side effects On 24 October the European
More informationPARACOD Tablets (Paracetamol + Codeine phosphate)
Published on: 22 Sep 2014 PARACOD Tablets (Paracetamol + Codeine phosphate) Composition PARACOD Tablets Each effervescent tablet contains: Paracetamol IP...650 mg Codeine Phosphate IP... 30 mg Dosage Form/s
More informationMEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII)
MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place away from children. If a child accidentally takes ZUBSOLV, this is a
More informationDrug Therapy Guidelines
Drug Therapy Guidelines Applicable Medical Benefit Effective: 6/15/18 Pharmacy- Formulary 1 x Next Review: 6/19 Pharmacy- Formulary 2 x Date of Origin: 4/99 Antiemetic Agents: Zofran /ODT (ondansetron/ondansetron
More informationPackage leaflet: Information for the patient. Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide
Package leaflet: Information for the patient Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide This medicine is subject to additional monitoring. This will allow quick identification of
More informationMedication Guide REMERONSolTab (rĕm' - ĕ - rŏn - sŏl' tăb) (mirtazapine) Orally Disintegrating Tablets
Medication Guide REMERONSolTab (rĕm' - ĕ - rŏn - sŏl' tăb) (mirtazapine) Orally Disintegrating Tablets Read the Medication Guide that comes with REMERONSolTab before you start taking it and each time you
More informationPRODUCT MONOGRAPH. FLOCTAFENINE Floctafenine Tablets 200 mg and 400 mg THERAPEUTIC CLASSIFICATION. Anti-inflammatory, Analgesic
0 PRODUCT MONOGRAPH FLOCTAFENINE Floctafenine Tablets 200 mg and 400 mg THERAPEUTIC CLASSIFICATION Anti-inflammatory, Analgesic INFORMATION FOR THE PATIENT FLOCTAFENINE, which has been prescribed to you
More informationABSTRAL Sublingual Tablets
ABSTRAL Sublingual Tablets Fentanyl (as citrate) Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about It does not contain all the available information.
More informationDrug Use Criteria: Oral Serotonin 5-HT3 Receptor Antagonists for Nausea and Vomiting
Texas Vendor Drug Program Drug Use Criteria: Oral Serotonin 5-HT3 Receptor Antagonists for Nausea and Vomiting Publication History Developed September 1996. Revised July 2018; September 2016; June 2015;
More informationLevocetirizine dihydrochloride
INSERT TEXT UAP Levocetirizine dihydrochloride Allerzet 5 mg Tablet Antihistamine FORMULATION Each film-coated tablet contains: Levocetirizine dihydrochloride.. 5 mg PRODUCT DESCRIPTION Levocetirine 5
More informationMABEES. MFR & Basic EMT Epinephrine Study
MABEES MFR & Basic EMT Epinephrine Study Acknowledgements This program is a State of Michigan approved special study designed by members of the Oakland County Medical Control Authority American CME developed
More informationPART III: CONSUMER INFORMATION SAPHRIS (asenapine sublingual tablets)
PART III: CONSUMER INFORMATION SAPHRIS (asenapine sublingual tablets) This leaflet is part III of a three-part "Product Monograph" published when SAPHRIS was approved for sale in Canada and is designed
More informationSTATE OF WEST VIRGINIA DEPARTMENT OF HEALTH AND HUMAN RESOURCES MEMORANDUM
Joe Manchin III Governor February STATE OF WEST VIRGINIA DEPARTMENT OF HEALTH AND HUMAN RESOURCES Martha Yeager Walker Secretary MEMORANDUM TO: FROM: West Virginia EMS Agencies West Virginia EMS Providers
More informationReference ID:
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZUPLENZ safely and effectively. See full prescribing information for ZUPLENZ. ZUPLENZ (ondansetron)
More informationparts of the gastrointenstinal tract. At the end of April 2008, it was temporarily withdrawn from the US Market because of problems related to
parts of the gastrointenstinal tract. At the end of April 2008, it was temporarily withdrawn from the US Market because of problems related to crystallization of the drug, which caused unreliable drug
More informationPackage leaflet: Information for the user. Zomig Rapimelt 2.5 mg orodispersible tablets zolmitriptan
Package leaflet: Information for the user Zomig Rapimelt 2.5 mg orodispersible tablets zolmitriptan Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationHave you already tried different drugs for your schizophrenia? Here s another option you and your doctor may want to consider.
Have you already tried different drugs for your schizophrenia? Here s another option you and your doctor may want to consider. 1 Benefits of Clozapine Clozapine may work when other medications don t. Doctors
More informationPATIENT INFORMATION. CRESEMBA (Crē sem bah) (isavuconazonium sulfate) Capsules, for oral administration
PATIENT INFORMATION CRESEMBA (Crē sem bah) (isavuconazonium sulfate) Capsules, for oral administration CRESEMBA (Crē sem bah) (isavuconazonium sulfate) For injection, for intravenous administration Read
More informationPublic Assessment Report. Scientific discussion. Abstral, sublingual tablet 50, 100, 200, 300, 400, 600 and 800 μg. (Fentanyl citrate)
Public Assessment Report Scientific discussion Abstral, sublingual tablet 50, 100, 200, 300, 400, 600 and 800 μg (Fentanyl citrate) SE/H/575/01-07/DC This module reflects the scientific discussion for
More informationChildren Enteric coated tablet : 1-3 mg/kg per day in divided doses.
Ultrafen Tablet/SR Tablet/Suppository/Gel Description Ultrafen is a preparation of Diclofenac is a non-steroidal antiinflammatory agent with marked analgesic, anti-inflammatory and antipyretic properties.
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Ebateva 10 mg Orodispersible Tablets Ebateva 20 mg Orodispersible Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One orodispersible
More informationPackage leaflet: Information for the user. Colobreathe 1,662,500 IU inhalation powder, hard capsules Colistimethate sodium
Package leaflet: Information for the user Colobreathe 1,662,500 IU inhalation powder, hard capsules Colistimethate sodium Read all of this leaflet carefully before you start using this medicine because
More informationLIDOCAINE HYDROCHLORIDE TOPICAL SOLUTION USP 4%
LIDOCAINE HYDROCHLORIDE TOPICAL SOLUTION USP 4% PRODUCT OVERVIEW: Lidocaine Hydrochloride SOLUTION Rx only DESCRIPTION Lidocaine Hydrochloride Topical Solution USP 4% contains a local anesthetic agent
More informationDulcolax Tablets and Dulcolax Suppositories Bisacodyl
Consumer Medicine Information Tablets and Suppositories Bisacodyl What is in this leaflet 1. What is used for 2. Before you use a) When you must not use b) Before you start to use c) Pregnancy d) Breastfeeding
More informationOlanzapine: MedlinePlus Drug Information
Olanzapine (oh lan' za peen) URL of this page: IMPORTANT WARNING: Studies have shown that older adults with dementia (a brain disorder that affects the ability to remember, think clearly, communicate,
More informationShared Care Agreement for Donepezil, Galantamine, Rivastigmine and Memantine
Clinical SECONDARY CARE SECTION TO BE COMPLETED BY INITIATING DOCTOR Patient s Name: Date of Birth: NHS Number: Date Treatment Started: Name of drug: (Add Date) One copy of information leaflet given to
More informationAVIOMARIN 50 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER AVIOMARIN 50 mg tablets DIMENHYDRINATE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationPharmacy Choice Olanzapine, Pharmacy Choice Olanzapine ODT Olanzapine
, ODT Olanzapine Consumer Medicine Information Except where indicated, "Pharmacy Choice Olanzapine" refers to both the tablets and the Pharmacy Choice Olanzapine ODT orally disintegrating tablet. What
More informationBefore you take SAPHRIS. When you must not take it
SAPHRIS 5mg and 10mg sublingual wafers Asenapine Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about SAPHRIS. It does not contain all the available information.
More informationPATIENT INFORMATION BREO ELLIPTA
PATIENT INFORMATION BREO ELLIPTA [BRE-oh e-lip-ta] (fluticasone furoate and vilanterol inhalation powder) for oral inhalation What is BREO ELLIPTA? BREO ELLIPTA combines an inhaled corticosteroid (ICS)
More informationThis leaflet answers some common questions about Momex SR Tablets.
Momex SR Modified (Sustained) Release Tablets [Morphine sulphate] CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Momex SR Tablets. It does not contain
More information2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 PRODUCT NAME TROPISETRON-AFT tropisetron hydrochloride (equivalent to 2 mg or 5 mg tropisetron) per ampoule. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains 1 mg of tropisetron 1 2 ml ampoule
More informationPackage leaflet: Information for the user. Tetrabenazine 25 mg tablets. tetrabenazine
Package leaflet: Information for the user Tetrabenazine 25 mg tablets tetrabenazine Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE SCOPE Provincial APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Pharmacy Services PARENT DOCUMENT TITLE, TYPE AND NUMBER Not applicable DOCUMENT # INITIAL EFFECTIVE DATE REVISION
More informationMedication is just part of the management of these illnesses. Other therapies are also helpful; you may wish to discuss these with your prescriber.
Know Your Medicines Duloxetine The purpose of this leaflet is to give you some general information on duloxetine, and is intended as a guide only. This should be read in conjunction with the official patient
More informationEMS Region Medication List 2010
EMT-B MEDICATIONS Patient Assisted Medications (PAM) and Ambulance Stock Medications Medication Protocol/Use Dose Auto-injector (Epi-pen) Glucose (Oral) Metered-Dose Inhaler (MDI) Allergic/Anaphylactic
More information